Histamine as a Molecular Transducer of Adaptation to Exercise

NCT05206227 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Postexercise Hypotension

Interventions

BEHAVIORAL: Aerobic Exercise
DRUG: alpha-FMH
BEHAVIORAL: Resistance and Aerobic Exercise
DRUG: Antihistamine

Sponsor

University of Oregon